MA33368B1 - Préparation de chlorhydrate de nalmefene à partir de naltrexone - Google Patents

Préparation de chlorhydrate de nalmefene à partir de naltrexone

Info

Publication number
MA33368B1
MA33368B1 MA34465A MA34465A MA33368B1 MA 33368 B1 MA33368 B1 MA 33368B1 MA 34465 A MA34465 A MA 34465A MA 34465 A MA34465 A MA 34465A MA 33368 B1 MA33368 B1 MA 33368B1
Authority
MA
Morocco
Prior art keywords
naltrexone
nalmefene hydrochloride
preparation
producing
hydrochloride
Prior art date
Application number
MA34465A
Other languages
English (en)
Inventor
Faveri Carla De
Mauro Casarin
Michele Brusegan
Original Assignee
Lundbeck & Co As H
Abu Ghazaleh Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43222172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33368(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H, Abu Ghazaleh Intellectual Prop filed Critical Lundbeck & Co As H
Publication of MA33368B1 publication Critical patent/MA33368B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention porte sur un procédé pour la production de chlorhydrate de nalmefene à partir de naltrexone, lequel procédé est particulièrement bien adapté pour une application industrielle à grande échelle et s'est avéré efficace pour donner un rendement de production élevé et pour fournir du sel de type chlorhydrate de nalmefene extrêmement pur.
MA34465A 2009-05-25 2010-05-21 Préparation de chlorhydrate de nalmefene à partir de naltrexone MA33368B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200900650 2009-05-25
US18102209P 2009-05-26 2009-05-26
PCT/DK2010/050110 WO2010136039A1 (fr) 2009-05-25 2010-05-21 Préparation de chlorhydrate de nalmefene à partir de naltrexone

Publications (1)

Publication Number Publication Date
MA33368B1 true MA33368B1 (fr) 2012-06-01

Family

ID=43222172

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34465A MA33368B1 (fr) 2009-05-25 2010-05-21 Préparation de chlorhydrate de nalmefene à partir de naltrexone

Country Status (35)

Country Link
US (1) US8598352B2 (fr)
EP (1) EP2435439B8 (fr)
JP (1) JP5794980B2 (fr)
KR (1) KR101716522B1 (fr)
CN (1) CN102459276B (fr)
AR (1) AR076891A1 (fr)
AU (1) AU2010252392B2 (fr)
BR (1) BRPI1010975B1 (fr)
CA (1) CA2763093C (fr)
CL (1) CL2011002974A1 (fr)
CO (1) CO6470832A2 (fr)
CR (1) CR20110612A (fr)
DK (1) DK2435439T3 (fr)
DO (1) DOP2011000362A (fr)
EA (1) EA019331B1 (fr)
ES (1) ES2564006T3 (fr)
GE (1) GEP20146190B (fr)
HR (1) HRP20160110T1 (fr)
HU (1) HUE026892T2 (fr)
IL (1) IL216422A (fr)
MA (1) MA33368B1 (fr)
ME (1) ME02622B (fr)
MX (1) MX2011012502A (fr)
MY (1) MY158251A (fr)
NZ (1) NZ596988A (fr)
PL (1) PL2435439T3 (fr)
RS (1) RS54599B1 (fr)
SG (1) SG176205A1 (fr)
SI (1) SI2435439T1 (fr)
SM (1) SMT201600061B (fr)
TN (1) TN2011000590A1 (fr)
TW (1) TWI469985B (fr)
UA (1) UA106752C2 (fr)
WO (1) WO2010136039A1 (fr)
ZA (1) ZA201108659B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2580201B1 (fr) 2010-06-11 2017-08-02 Rhodes Technologies Procédés catalysés par métal de transition pour la préparation de composés de n-allyle et utilisation de ceux-ci
DK2635586T3 (en) 2010-11-05 2017-03-27 H Lundbeck As PROCEDURE FOR THE PREPARATION OF NALTREXON
CN103012416B (zh) * 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
TWI560170B (en) 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CN102584840A (zh) * 2011-12-28 2012-07-18 南京优科生物医药有限公司 一种制备纳美芬化合物的方法
WO2013164383A1 (fr) 2012-05-03 2013-11-07 H. Lundbeck A/S Procédé de préparation de naltrexone
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
CN103204859B (zh) * 2013-04-25 2015-12-02 四川海思科制药有限公司 一种盐酸纳美芬化合物及其制备方法
AR096851A1 (es) * 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
JP6448645B2 (ja) 2013-12-20 2019-01-09 ハー・ルンドベック・アクチエゼルスカベット メランコリアの特徴を伴う抑うつ障害を処置するための、カッパ−活性を伴うオピオイド受容体拮抗薬およびボルチオキセチンの使用
AU2015250611A1 (en) 2014-04-22 2016-11-24 H. Lundbeck A/S Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
CN104513251A (zh) * 2014-11-28 2015-04-15 安徽悦康凯悦制药有限公司 一种盐酸纳美芬的制备方法
US9757372B2 (en) * 2015-03-25 2017-09-12 Taiwanj Pharmaceuticals Co., Ltd. Toll-like receptor 4 antagonists and use in autoimmune liver diseases
RU2712232C1 (ru) * 2018-10-05 2020-01-27 Федеральное государственное унитарное предприятие "Научно-исследовательский институт гигиены, профпатологии и экологии человека" Федерального медико-биологического агентства Улучшенный способ получения налмефена из налтрексона
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
JP2023548356A (ja) 2020-11-02 2023-11-16 ローズ テクノロジーズ ノルオキシモルホンを精製するための方法
WO2022165040A1 (fr) 2021-01-28 2022-08-04 Rhodes Technologies Procédé de cristallisation de chlorhydrate de nalmefène
CN117843650A (zh) * 2023-12-27 2024-04-09 南京海纳医药科技股份有限公司 一种盐酸纳美芬的精制方法
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
US4322426A (en) 1980-04-28 1982-03-30 E. I. Du Pont De Nemours And Company 17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
US4535157A (en) * 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
US7687646B2 (en) 2006-03-28 2010-03-30 Azad Pharmaceutical Ingredients, Ag Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
GB2447013A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition containing buprenorphone and nalmefene

Also Published As

Publication number Publication date
EP2435439A1 (fr) 2012-04-04
CA2763093A1 (fr) 2010-12-02
ES2564006T3 (es) 2016-03-17
CN102459276B (zh) 2016-09-21
EP2435439B1 (fr) 2016-01-06
ME02622B (fr) 2017-06-20
MX2011012502A (es) 2011-12-12
CA2763093C (fr) 2017-03-07
RS54599B1 (sr) 2016-08-31
EA019331B1 (ru) 2014-02-28
JP5794980B2 (ja) 2015-10-14
CR20110612A (es) 2012-02-22
AU2010252392A1 (en) 2012-01-12
MY158251A (en) 2016-09-30
WO2010136039A1 (fr) 2010-12-02
CL2011002974A1 (es) 2012-04-13
KR20120023704A (ko) 2012-03-13
DOP2011000362A (es) 2012-07-15
AU2010252392B2 (en) 2014-10-23
HRP20160110T1 (hr) 2016-03-11
TW201043634A (en) 2010-12-16
JP2012527489A (ja) 2012-11-08
US20120123123A1 (en) 2012-05-17
CN102459276A (zh) 2012-05-16
TN2011000590A1 (en) 2013-05-24
SG176205A1 (en) 2011-12-29
US8598352B2 (en) 2013-12-03
DK2435439T3 (en) 2016-02-29
SMT201600061B (it) 2016-07-01
ZA201108659B (en) 2013-02-27
BRPI1010975B1 (pt) 2021-08-24
PL2435439T3 (pl) 2016-05-31
BRPI1010975A2 (pt) 2015-10-20
EP2435439B8 (fr) 2016-05-18
SI2435439T1 (sl) 2016-06-30
EA201171461A1 (ru) 2012-05-30
KR101716522B1 (ko) 2017-03-14
CO6470832A2 (es) 2012-06-29
UA106752C2 (uk) 2014-10-10
NZ596988A (en) 2013-03-28
IL216422A (en) 2015-06-30
IL216422A0 (en) 2012-02-29
TWI469985B (zh) 2015-01-21
GEP20146190B (en) 2014-11-10
HUE026892T2 (en) 2016-07-28
AR076891A1 (es) 2011-07-13

Similar Documents

Publication Publication Date Title
MA33368B1 (fr) Préparation de chlorhydrate de nalmefene à partir de naltrexone
EP2330224A4 (fr) Cuivre de haute pureté et procédé pour la production électrolytique de cuivre de haute pureté
EP2441831A4 (fr) Procédé de production d'une protéine
EP2041778A4 (fr) Procédé de production de puces segmentées
EP2326443A4 (fr) Procédé de production d'objets contenant un nanométal ou un métal composite
EP2213180A4 (fr) Procédé de production d'une boisson carbonée
EP2423312A4 (fr) Procédé de production d'une plante du genre chrysanthème ayant des pétales contenant de la delphinidine
MY173940A (en) Process for producing pyrrole compound
EP2584055A4 (fr) Procédé d'élimination d'ions cuivre d'une solution de chlorure de nickel contenant du cuivre, et processus de production de nickel électrolytique
EP2336346A4 (fr) Procédé de production d'acrylamide
EP1997817A4 (fr) Méthode de purification du carbonate d'éthylène, procédé de production de carbonate d'éthylène purifié et carbonate d'éthylène
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
EP2502508A4 (fr) Procédé de production d'une boisson gazeuse
EP2179995A4 (fr) Procédé de fabrication d'un sel d'ammonium purifié de bis-sulfonylimide fluoré
MX2012005760A (es) Metodo para la eliminacion de cloruro en solucion de sulfato de cinc.
EP2098480A4 (fr) Procédé de production de pentafluorure d'iode
EA200700906A1 (ru) Низкотемпературный промышленный процесс
EP2138514A4 (fr) Procédé de production d'amidon ayant une teneur élevée d'amidon moins digérable
EP1936664A4 (fr) Procédé de production d'une tranche liée
EP2692877A4 (fr) Alliage de cuivre et procédé de production d'un alliage de cuivre
EP2554247A4 (fr) Membrane exempte de défauts utilisée pour séparer l'hydrogène, procédé de production de cette membrane et procédé de séparation de l'hydrogène
EP2096103A4 (fr) Procédé pour la production d'une bétaïne
EP2474995A4 (fr) Procédé de production d'une plaquette de silicium sur isolant
EP2452918A4 (fr) Procédé de production de fluorure d'hydrogène
EP1816186A4 (fr) Procédé de production d'une boisson fermentée d'une grande stabilité